Your browser doesn't support javascript.
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon ß-1b.
Hong, Sun In; Ryu, Byung-Han; Chong, Yong Pil; Lee, Seungjun; Kim, Sunjoo; Kim, Ho Cheol; Hong, Kyung-Wook; Bae, In-Gyu; Cho, Oh-Hyun.
  • Hong SI; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Ryu BH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Chong YP; Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Lee S; Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Kim S; Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Kim HC; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Hong KW; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Bae IG; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Cho OH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic addres
Int J Antimicrob Agents ; 56(2): 106052, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-601373
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Adjuvants, Immunologic / Coronavirus Infections / Drug Therapy, Combination / Betacoronavirus / Antimalarials Type of study: Case report / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Adjuvants, Immunologic / Coronavirus Infections / Drug Therapy, Combination / Betacoronavirus / Antimalarials Type of study: Case report / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article